Melphalan Tablets

Product/Composition Melphalan Tablets
Strength 2mg, 5mg
Form Tablets
Production Capacity 10 Million Tablet/Month
Packaging 1 X 10 Tablets / Box
Therapeutic use Anti Cancer
Package Insert/Leaflet Available upon request

Melphalan Tablets are a prescription medicine that belongs to the class of alkylating agents, used primarily in cancer treatment.

Here are the key details:

  • Main Use:

    • Treats multiple myeloma, a type of blood cancer.

    • Used for certain solid tumors or before bone marrow transplantation in some cases.

  • How It Works: Melphalan works by interfering with the DNA of rapidly dividing cancer cells, preventing them from multiplying and leading to cell death.

  • Administration: Taken orally, usually once daily or as prescribed by the doctor. The dosage is individualized based on the type of cancer, patient’s health, and treatment plan.

  • Common Side Effects: Nausea, vomiting, diarrhea, loss of appetite, fatigue, mild hair thinning, or mouth sores.

  • Serious Concerns:

    • Can cause bone marrow suppression, leading to low blood counts, increasing the risk of infections, anemia, or bleeding.

    • May cause severe allergic reactions or long-term risk of secondary cancers.

    • Liver or kidney problems may occur in some patients.

  • Precautions:

    • Regular monitoring of blood counts, liver, and kidney function is required during treatment.

    • Patients should avoid exposure to infections due to reduced immunity.

    • Inform the doctor of all other medications to prevent interactions.

  • Storage: Store at room temperature, away from moisture, heat, and direct sunlight.